alzheimer'

Here is the study: Combined metabolic activators improve cognitive functions in Alzheimer’s disease patients: a randomised, double-blinded, placebo-controlled phase-II trial 2023 ncbi.nlm.nih.gov/pmc/articl... Background: Alzheimer’s disease (AD) is associated with metabolic abnormalities...